Rezultati

eNauka >  Results >  A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
Title: A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
Authors: Fleischmann, Roy M.; Damjanov, Nemanja ; Kivitz, Alan J.; Legedza, Anna; Hoock, Thomas; Kinnman, Nils
Issue Date: 2015
Publication: Arthritis and Rheumatism
ISSN: 2326-5191 Arthritis & Rheumatology Search Idenfier
Type: Article
Collation: vol. 67 br. 2 str. 334-343
DOI: 10.1002/art.38949
WoS-ID: 000349218500004
Scopus-ID: 2-s2.0-84922808076
URI: https://enauka.gov.rs/handle/123456789/169394
Metadata source: Migrirano iz RIS podataka
M-category: 
21aM21a

95
SCOPUSTM
87
OpenCitations
87
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.